ResearcherThe Wistar InstituteActive in the last 2 years
Ellen Puré
Matched on ORCID iD 0000-0003-2107-3711; OpenAlex author ID A5004098027; NIH RePORTER profile ID 1864184. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 1
- Labs led
- 2
- Collaborators
- 10
2014: 1 grant · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 3
- Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer. Co-author DOI 10.1038/s41556-025-01697-8↗
- Mechanisms of PDAC subtype heterogeneity and therapy response. Co-author DOI 10.1016/j.trecan.2022.08.005↗
- Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma. Last author DOI 10.1172/jci.insight.92232↗
Grants 1
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Elisa Espinet · 1 shared paper, 2022 · strength 0.22
- Shiv K. Singh · 1 shared paper, 2022 · strength 0.22
- Lukas Klein · 1 shared paper, 2022 · strength 0.22
- David Tsai Ting · 1 shared paper, 2025 · strength 0.17
- Taslim Ahmed Al-Hilal · 1 shared paper, 2025 · strength 0.17
- Matteo Ligorio · 1 shared paper, 2025 · strength 0.17
- David Lagares · 1 shared paper, 2025 · strength 0.17
- Raghu Kalluri · 1 shared paper, 2025 · strength 0.17
- Albert Lo · 1 shared paper, 2017 · strength 0.07
- Chung‐Pin Li · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.